IVF INVO Fertility, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1417926 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.2%
TTM net income YoY82.9%
TTM EPS YoY138.9%
Revenue 3-yr CAGR61.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-72.2%
Net margin-59.9%
FCF margin—
EBITDA margin-64.6%
Returns
ROE-40.5%
ROA-21.6%
ROIC (approx.)-34.7%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets29.4%
Debt / equity0.05x
Current ratio1.00x
Interest coverage-5.06x
Cash quality & payout
Operating cash flow / net income0.98x
Accruals ratio-0.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $6.84M | $6.53M | $3.02M | $822,196 | $4.16M |
| Cost of revenue | $30,571 | $12,201 | $1.97M | $331,523 | $145,052 |
| Gross profit | $6.81M | $6.52M | $1.05M | $490,673 | $4.02M |
| R&D expense | — | $4,880 | $165,945 | $544,043 | $216,430 |
| SG&A expense | $7.69M | $8.07M | $7.49M | $9.98M | $9.02M |
| Operating income | -$7.24M | -$6.63M | -$6.77M | -$10.63M | -$5.22M |
| Interest expense | $1.30M | $1.04M | $925,909 | $59,445 | $1.27M |
| Pretax income | -$5.49M | -$7.60M | -$8.01M | -$10.89M | -$6.65M |
| Income tax | -$150,371 | $140,202 | $27,786 | $2,872 | $4,764 |
| Net income | -$23.32M | -$9.26M | -$8.03M | -$10.89M | -$6.65M |
| EBITDA | -$6.56M | -$5.71M | -$6.57M | -$10.55M | -$5.19M |
| EPS (basic) | -214.64 | -3,782.65 | -67.37 | -17.97 | -0.63 |
| EPS (diluted) | -214.64 | -3,782.65 | -67.37 | -17.97 | -0.63 |
| Weighted avg. shares (diluted) | 117,083 | 2,514 | 119,264 | 606,130 | 10.63M |
| Balance sheet | |||||
| Cash & equivalents | $0 | $619,520 | $232,424 | $90,135 | $5.68M |
| Receivables | $217,263 | $113,108 | $140,550 | $77,149 | $50,470 |
| Inventory | $225,253 | $219,764 | $264,507 | $263,602 | $287,773 |
| Current assets | $2.76M | $1.26M | $1.26M | $621,087 | $6.31M |
| PP&E, net | $386,165 | $466,684 | $826,418 | $436,729 | $501,436 |
| Goodwill | $5.88M | $5.88M | $5.88M | — | — |
| Intangibles | $1.33M | $3.28M | $4.09M | — | $132,093 |
| Total assets | $20.22M | $46.08M | $18.51M | $3.71M | $9.99M |
| Current liabilities | $10.33M | $17.87M | $8.00M | $3.34M | $1.17M |
| Short-term debt | $1.27M | $6.34M | — | — | — |
| Long-term debt | $744,725 | $1.13M | — | — | — |
| Total debt | $2.02M | $7.47M | — | — | — |
| Total liabilities | $13.00M | $26.04M | $17.61M | $4.69M | $2.68M |
| Shareholders' equity | $7.22M | $12.58M | $892,825 | -$977,612 | $7.31M |
| Net debt | $2.02M | $6.85M | — | — | — |
| Shares outstanding | 119,358 | 3,111 | 207,711 | 608,611 | 11.93M |
| Cash flow statement | |||||
| Operating cash flow | -$7.01M | -$2.97M | -$4.76M | -$6.60M | -$6.03M |
| Capital expenditure | $43,412 | $183,703 | $444,722 | $10,785 | $415,710 |
| Free cash flow | -$7.06M | -$3.16M | -$5.20M | -$6.61M | -$6.45M |
| Investing cash flow | -$2.75M | $363,895 | -$2.49M | -$81,217 | -$2.15M |
| Financing cash flow | $11.10M | $3.12M | $7.39M | $1.09M | $3.77M |
| Depreciation & amortization | $677,364 | $919,603 | $200,894 | $77,301 | $27,760 |
| Stock-based compensation | $162,920 | — | — | $1.62M | $1.54M |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.